{"title":"El factor humano en la gota","authors":"Xavier Tena","doi":"10.1016/j.semreu.2013.09.002","DOIUrl":null,"url":null,"abstract":"<div><p>Although gout is a highly prevalent disease with significant clinical repercussions, it continues to a chronic disease with very low treatment adherence. The stigma associated with the disease, lack of treatment observance and others related to the physician and clinical practice are the most striking, specially the tendency for these patients to be managed in primary care, a certain lack of interest, and the low priority given to teaching among rheumatologists, as well as variation in adherence to recommendations established in clinical practice guidelines. Optimization strategies include improving the quality of prescriptions for specific drugs, being aware of patients’ perceptions of the disease, being proactive against lack of treatment adherence, and applying a comprehensive approach to treatment. The strong involvement of rheumatologists in the treatment of this disease is essential to achieve the desired results.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"15 1","pages":"Pages 3-5"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2013.09.002","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminarios de la Fundación Espa?ola de Reumatología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1577356613000602","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Although gout is a highly prevalent disease with significant clinical repercussions, it continues to a chronic disease with very low treatment adherence. The stigma associated with the disease, lack of treatment observance and others related to the physician and clinical practice are the most striking, specially the tendency for these patients to be managed in primary care, a certain lack of interest, and the low priority given to teaching among rheumatologists, as well as variation in adherence to recommendations established in clinical practice guidelines. Optimization strategies include improving the quality of prescriptions for specific drugs, being aware of patients’ perceptions of the disease, being proactive against lack of treatment adherence, and applying a comprehensive approach to treatment. The strong involvement of rheumatologists in the treatment of this disease is essential to achieve the desired results.